JRM–CC is a forum for a broad range of interesting clinical papers including case studies, case series, pilot studies, educational papers, personal opinions, technical papers, short reports, PhD-thesis summaries, position papers, book reviews. etc. The main criterion for considering a submission will be the relevance for clinical practice in Rehabilitation Medicine.
Submission of a manuscript is held to imply that it has not previously been published and is not otherwise submitted for publication, except as an abstract (which in that case has to be stated). If problems with the submission or creating an account occurs please contact us via e-mail.
In writing your paper, you are encouraged to review articles in the area you are addressing including those that have been previously published in the journal, and to reference them where you feel it is appropriate. This will enhance context, coherence, and continuity for our readers. After revision the references should be checked to see if there are new references available. Submit the manuscript (including tables and figures) as a styled Microsoft Word file and photographs as separate EPS or TIFF files with a resolution of at least 300 dpi. Black-and-white digital images should be in gray scale mode and colour images saved in CMYK, not index or RGB, colour mode.
It is possible to upload one manuscript file and three image files at a time. If you need to upload more image files than three, you will be given the opportunity to do so after pressing "Upload". Please name the manuscript file according to the formula "Firstauthorname.doc" and any image files "Firstauthornamefig1.doc" etc. When uploading revised manuscripts, please name the manuscript file manuscript number + "ver" + version number in Roman numerals, eg. 123456verIII.doc. The corresponding author will be notified that the manuscript has been received.
High-quality English language is of primary importance when you submit your manuscript, so that reviewers and editors can fully understand the contents and give your work a fair review. All papers should be written in English (British English is preferable but American English can be accepted if written by Americans). Before you submit your manuscript we strongly recommend that you have it checked by an English-speaking colleague and/or use a professional language editing service, to ensure that it reads well. Upon acceptance, all papers will undergo English language editing for minor issues and style consistency. Any more extensive editing necessary at this stage will be invoiced to the authors in addition to the regular publication charges. Please note that the use of professional language editing services is not a requirement for publication, and does not guarantee that the article will be selected for peer review or accepted
It is not acceptable to submit papers already published elsewhere or simultaneously submit a paper to another journal. Furthermore, the paper must not be under review in another journal. Accompanying the manuscript should be a copy of all references mentioned in the particular paper still not published and articles by the same authors on the same subject submitted elsewhere.
It is advisable to give suggestions on 2–3 reviewers that are well versed in the area of the manuscript. However, it is the Editor who will make the final decision on the choice of reviewers.
Article length
The following should be included:
Title
Name
Institute / affiliation
Date of defense
Promotor(es)
A summary
A box with the 5 most important conclusions
Figures with the most prominent outcomes
A bibliography of publications on which the thesis is based
Also a photo of the defendent
All persons designated as authors must participate sufficiently in the work to take public responsibility in its contents. For criteria for authors see "Uniform requirements for manuscripts submitted to biomedical journals" available here. In essence authorship credit should be based on 1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; and 3) final approval of the version to be published. Authors should meet conditions 1, 2, and 3. Participation solely in the acquisition of funding or the collection of data does not justify authorship, nor does general supervision of the research group. The author who submits the manuscript should state if the authors meet these criteria. If there are 5 authors or more, a statement on each author's contribution must be described in the accompanying letter. In multicenter trials group members not meeting these criteria should be listed, with their permission, in the acknowledgement or appendix. All persons mentioned in the Acknowledgement should have accepted this to the responsible author.
When submitting a paper to our journal you are allowed to deposit the paper in a manuscript form at your website or university repository with acknowledgement where it is considered for publication.
Authors are responsible for recognising and disclosing financial and other conflicts of interest that might bias their work. They should acknowledge all financial support for the work and other financial or personal connections to the work in the manuscript. Where necessary, it should be stated that the funding agency e.g. a pharmaceutical or instrumental company, has had no influence of the interpretation of data and the final conclusions drawn. Thus, authors must disclose any commercial associations that might impose a conflict of interest in connection within the study. If they have no interests to declare, this should be stated (recommended wording: The authors have no conflicts of interest to declare).
When reporting studies on human subjects all authors are required to follow the ICMJE requirements on privacy and informed consent. Information that could be used to identify patients, in the form of written descriptions, photographs, and pedigrees, should not be published unless it is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that the patient be shown the manuscript to be published. Where someone is deceased, please ensure you have written consent from the family or estate.
Clinical trials and studies involving animal experiments must be approved by a local ethics committee. The researchers are strongly advised to register clinical trials to public trial registers, such as www.clinicaltrials.gov. Trial registration numbers should be included, and full details in the methods section.
All manuscripts are first reviewed by one of the Editors. Some papers may be rejected at this stage as they do not meet basic scientific principles or deal with topics beyond the scope of the journal. All other manuscripts will be entered into our peer review system and are sent to reviewers with special expertise in the area. The review is single blinded according to the decided policy of the journal. After receiving the comments from the reviewers, it will be decided by the Editors whether the manuscript should be accepted directly, which in practice is rare, subjected to a minor or major revision before decision about publication can be made, or rejected at this point.
After a paper has been accepted, the author(s) will be charged a publication fee, to cover the costs associated with running the journal. JRM-CC follows the HINARI waiver policy for developing countries. Regular fee: 650 euros/paper (max 2000 words, see section on article length for further details).
Longer articles: 850 euros/paper (max 3000 words, see section on article length for further details).
When publishing articles open access in this publication, the author(s) will retain the copyright in their work. We will however ask the author(s) to sign a license to publish, which gives us the non-exclusive right to publish the Version of Record of the article. This license to publish incorporates the Creative Commons license, CC-BY-NC, which dictates what others can do with the article once it has been published. Please note that authors are themselves responsible for obtaining permission for reproducing copyrighted material from other sources.
Page proofs are sent directly from the editorial office to the corresponding author, via e-mail as pdf-files. It is his or her full responsibility to read and check the proofs against the manuscript. One proof should be signed and returned to the Editorial Office within four days by airmail.
Supplementary material can include for example video- and audio files but also figures, tables, and datasets. Including supplementary material with your article can make it more discoverable, and help maximizing downloads and citations.
Video abstracts can be a good way of getting others to engage with your research, ultimately increasing the visibility and impact of your work. Through a video abstract you can introduce the article in your own words, telling readers what the unique contribution of your article is and why they should read it. We recommend keeping a video abstract short and to the point (no more than a few minutes) and that you use images, charts or tables to help explain the focus of your article. Consider the aim of the video throughout – to get people to read your article. The best video format is MP4 although other video formats such as MOV and MPEG4 are also supported. The minimum dimension is 426 x 240 and the max dimension is 3840 x 2160.
Please make sure to include any supplementary files at the same time as you submit your manuscript, although a video abstract can be sent upon acceptance instead.
Supplementary material that requires language editing or typesetting from the editorial team will involve a fee of 25 €/supplement (extensive material might count as two supplementary files due to the extra workload involved). Video files will be published free of charge.
| Major corrections will be dealt with as follows: |
|
|
We follow the Committee on Publication Ethics (COPE) guidelines on appeals to editorial decisions and complaints about the management of the peer review process.
The editors don’t expect frequent appeals and rarely reverse the original decisions. The decision to reject a manuscript will often involve the editor’s judgment of priority/ importance/relevance. These are things which authors usually cannot address through an appeal. However, if you believe that there is a case to be made for a genuine appeal please submit an appeal letter to the editorial office detailing the basis for the appeal. Should you as an author wish to comment on aspects of the journal’s editorial management, you are welcome to submit such a comment to the editorial office.
